Client News

Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc.

Lindis Blood Care Announces Publication of Final Results from Pivotal REMOVE Study with CATUVAB® in the Journal of Clinical Anesthesia

Abivax to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review

InflaRx Regains Compliance with Nasdaq Minimum Bid Price Requirement

Progress in Clinical Development for Alzheimer´s and Other Indications: Galimedix Therapeutics Successfully Completes Phase 1 Study With Oral Small Molecule, GAL-101, an Amyloid Beta Aggregation Modulator

AFYREN Announces its 2025 Half-Year Financial Results

ARTCLINE Announces Closing of €5 Million Financing

Abivax Presents First Half 2025 Financial Results

Newron to Present Data and Updates on its Clinical Program Evaluating Evenamide as an Add-on Treatment for Schizophrenia at the 2025 World Congress of Biological Psychiatry (WCBP)

Heidelberg Pharma Announces New Clinical Data on Lead ATAC Candidate HDP-101 to be Presented at International Myeloma Society Annual Meeting 2025